Acumen Pharmaceuticals, Inc. — All Filings
328 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001964306-26-000026 | Jan 8, 2026 | — |
| 144 | — | 0001964306-26-000027 | Jan 8, 2026 | — |
| 144 | — | 0001964306-26-000024 | Jan 8, 2026 | — |
| 144 | — | 0001964306-26-000018 | Jan 7, 2026 | — |
| 144 | — | 0001964306-26-000019 | Jan 7, 2026 | — |
| 144 | — | 0001964306-26-000020 | Jan 7, 2026 | — |
| 144 | — | 0001964306-26-000021 | Jan 7, 2026 | — |
| 4 | FORM 4 | 0001628280-26-001261 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001628280-26-001262 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001628280-26-001263 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001628280-26-001264 | Jan 7, 2026 | Jan 5, 2026 |
| 144 | — | 0001964306-26-000017 | Jan 7, 2026 | — |
| 4 | FORM 4 | 0001628280-26-001265 | Jan 7, 2026 | Jan 5, 2026 |
| 144 | — | 0001964306-26-000016 | Jan 7, 2026 | — |
| 144 | — | 0001964306-26-000015 | Jan 6, 2026 | — |
| 144 | — | 0001964306-26-000011 | Jan 6, 2026 | — |
| 144 | — | 0001964306-26-000012 | Jan 6, 2026 | — |
| 144 | — | 0001964306-26-000013 | Jan 6, 2026 | — |
| 144 | — | 0001964306-26-000014 | Jan 6, 2026 | — |
| 144 | — | 0001964306-26-000010 | Jan 5, 2026 | — |
| 144 | — | 0001964306-26-000008 | Jan 5, 2026 | — |
| 144 | — | 0001964306-26-000009 | Jan 5, 2026 | — |
| 144 | — | 0001964306-26-000006 | Jan 5, 2026 | — |
| 144 | — | 0001964306-26-000007 | Jan 5, 2026 | — |
| 424B5 | 424B5 | 0001628280-25-051852 | Nov 13, 2025 | — |
| 8-K | 8-K | 0001576885-25-000102 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001576885-25-000104 | Nov 12, 2025 | Sep 30, 2025 |
| 4 | FORM 4 | 0001586660-25-000003 | Nov 10, 2025 | Nov 6, 2025 |
| 8-K | 8-K | 0001628280-25-050800 | Nov 10, 2025 | Nov 6, 2025 |
| 3 | FORM 3 | 0001576885-25-000096 | Nov 10, 2025 | Nov 6, 2025 |
| SCHEDULE 13G/A | — | 0001846444-25-000017 | Aug 13, 2025 | — |
| 8-K | 8-K | 0001576885-25-000091 | Aug 12, 2025 | — |
| 10-Q | 10-Q | 0001576885-25-000093 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001576885-25-000087 | Jul 15, 2025 | — |
| 4 | FORM 4 | 0001576885-25-000082 | Jun 5, 2025 | Jun 4, 2025 |
| 8-K | 8-K | 0001576885-25-000072 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001576885-25-000084 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001576885-25-000078 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001576885-25-000079 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001576885-25-000081 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | — | 0001415889-25-015836 | Jun 5, 2025 | Jun 4, 2025 |
| 4 | FORM 4 | 0001576885-25-000080 | Jun 5, 2025 | Jun 4, 2025 |
| 8-K | 8-K | 0001576885-25-000062 | May 13, 2025 | — |
| 10-Q | 10-Q | 0001576885-25-000065 | May 13, 2025 | Mar 31, 2025 |
| DEFA14A | DEFA14A | 0001576885-25-000058 | Apr 23, 2025 | — |
| DEF 14A | DEF 14A | 0001576885-25-000057 | Apr 23, 2025 | Jun 4, 2025 |
| ARS | ARS | 0001576885-25-000059 | Apr 23, 2025 | Dec 31, 2024 |
| SCHEDULE 13D/A | — | 0001415889-25-009256 | Mar 31, 2025 | — |
| 10-K | 10-K | 0001576885-25-000049 | Mar 27, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0001576885-25-000051 | Mar 27, 2025 | — |